Phase 3Recruiting
Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
Sponsored by Wake Forest University Health Sciences
About this study
The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.
Enrolling at this location
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.